Novartis AG - Strategy, SWOT and Corporate Finance Report

Novartis AG - Strategy, SWOT and Corporate Finance Report


  • Products Id :- F417BF95-9BE0-4158-9BE8-61C908FCF226
  • |
  • Pages: 74
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Novartis AG-Strategy, SWOT and Corporate Finance Report

Summary

Novartis AG-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Novartis AG (Novartis or 'the company') is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is involved in the research, development, manufacture and marketing of medicines, eye care products and generic pharmaceuticals. In addition, it offers these products to treat cancer, cardiovascular, dermatological, neurological, ophthalmic, respiratory and infectious diseases, and immune disorders.It also conducts various research and development activities through its Novartis Institutes for BioMedical Research (NIBR). Novartis is headquartered in Basel, Switzerland.

Scope

- Detailed information on Novartis AG required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis

- An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments

- Intelligence on Novartis AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Novartis AG, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Novartis AG and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Novartis AG as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Novartis AG's business structure, strategy and prospects.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Company Snapshot 2

Table of Contents 5

Novartis AG: Company Overview 9

Novartis AG: Overview and Key Facts 9

Novartis AG: Overview 9

Novartis AG: Key Facts 9

Novartis AG: Key Employees 11

Novartis AG: Key Employee Biographies 13

Novartis AG: Major Products and Services 22

Novartis AG: Company History 24

Novartis AG: Management Statement 38

Novartis AG: Locations and Subsidiaries 40

Novartis AG: Key Competitors 41

Novartis AG: Company Analysis 42

Novartis AG: Business Description 42

Novartis AG: SWOT Analysis 44

Novartis AG: SWOT Overview 44

Novartis AG: Strengths 44

Novartis AG: Weaknesses 45

Novartis AG: Opportunities 46

Novartis AG: Threats 47

Novartis AG: Corporate Financial Deals Activity 49

Novartis AG: Financial Deals Overview 49

Novartis AG: Targets and Partners 51

Novartis AG: Top Deals 2014-2018YTD 56

Novartis AG: Advisors 57

Novartis AG: Top Legal Advisors 57

Novartis AG: Top Financial Advisors 57

Novartis AG: Mergers and Acquisitions 58

Novartis AG: Corporate Venturing 59

Novartis AG: Capital Raising 60

Novartis AG: Partnership 61

Novartis AG: Divestments 62

Novartis AG: Recent Developments 63

Novartis AG: News and Events Summary 63

Novartis AG: Contracts 67

Novartis AG: Regulatory and Legal Events 69

Novartis AG: Research & Development 69

Novartis AG: Strategy and Operations 70

Appendix 72

Contact Us 72

Methodology 72

About MarketLine 73

List of Figures

Figure 1: Novartis AG: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Novartis AG: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: Novartis AG: M&A Average Deal Size-Value (USD m)

Figure 4: Novartis AG: M&A

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 175 INR 12250
Site License
USD 350 INR 24500
Corporate User License
USD 525 INR 36750

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com